How I treat cancer: treatment of rheumatological side effects of immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How I treat cancer: treatment of rheumatological side effects of immunotherapy

Published:2020 Issue: Volume:4 Page:e000529
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Benesova Karolina^ORCID,Lorenz Hanns-Martin,Leipe Jan,Jordan Karin

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference18 articles.

1. Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignancies;Buder-Bakhaya;Cancer Immunol Immunother,2018

2. Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study;Kostine;Ann Rheum Dis,2018

3. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for immunotherapy of cancer (SITC) toxicity management Working Group;Puzanov;J Immunother Cancer,2017

4. Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors: a systematic review of the literature;Cappelli;Arthritis Care Res,2017

5. European Society for medical Oncology (ESMO) position paper on supportive and palliative care;Jordan;Ann Oncol,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2‐Positive Breast Cancer;International Journal of Breast Cancer;2024-01

2. Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse events;Journal for ImmunoTherapy of Cancer;2023-09

3. Distinct immune-effector and metabolic profile of CD8⁺ T cells in patients with autoimmune polyarthritis induced by therapy with immune checkpoint inhibitors;Annals of the Rheumatic Diseases;2022-08-03

4. How we identify and treat neuromuscular toxicity induced by immune checkpoint inhibitors;ESMO Open;2021-12

5. Diagnostik und Management rheumatischer "immune-related adverse events";Orthopädie & Rheuma;2021-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3